OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics
Ramón Cacabelos, Juan C. Carril, Ana Sanmartín, et al.
Elsevier eBooks (2019), pp. 191-424
Closed Access | Times Cited: 28
Ramón Cacabelos, Juan C. Carril, Ana Sanmartín, et al.
Elsevier eBooks (2019), pp. 191-424
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
The role of pharmacogenomics in adverse drug reactions
Ramón Cacabelos, Natalia Cacabelos, Juan C. Carril
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 5, pp. 407-442
Closed Access | Times Cited: 98
Ramón Cacabelos, Natalia Cacabelos, Juan C. Carril
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 5, pp. 407-442
Closed Access | Times Cited: 98
Sirtuins in Alzheimer’s Disease: SIRT2-Related GenoPhenotypes and Implications for PharmacoEpiGenetics
Ramón Cacabelos, Juan C. Carril, Natalia Cacabelos, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1249-1249
Open Access | Times Cited: 76
Ramón Cacabelos, Juan C. Carril, Natalia Cacabelos, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1249-1249
Open Access | Times Cited: 76
Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13302-13302
Open Access | Times Cited: 44
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13302-13302
Open Access | Times Cited: 44
Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease
Ramón Cacabelos, Juan C. Carril, Lola Corzo, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 1, pp. 27-57
Closed Access | Times Cited: 22
Ramón Cacabelos, Juan C. Carril, Lola Corzo, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 1, pp. 27-57
Closed Access | Times Cited: 22
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Ramón Cacabelos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3059-3059
Open Access | Times Cited: 48
Ramón Cacabelos
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3059-3059
Open Access | Times Cited: 48
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease
Ramón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 8, pp. 673-701
Closed Access | Times Cited: 42
Ramón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 8, pp. 673-701
Closed Access | Times Cited: 42
How plausible is an Alzheimer’s disease vaccine?
Ramón Cacabelos
Expert Opinion on Drug Discovery (2019) Vol. 15, Iss. 1, pp. 1-6
Open Access | Times Cited: 38
Ramón Cacabelos
Expert Opinion on Drug Discovery (2019) Vol. 15, Iss. 1, pp. 1-6
Open Access | Times Cited: 38
Chitosan-Coated Silver Nanourchins for Imatinib Mesylate Delivery: Biophysical Characterization, In-Silico Profiling, and Anti-Colon Cancer Efficacy
Sankha Bhattacharya, Aalind Joshi, Vishal Beldar, et al.
Molecular Pharmaceutics (2025)
Closed Access
Sankha Bhattacharya, Aalind Joshi, Vishal Beldar, et al.
Molecular Pharmaceutics (2025)
Closed Access
What have we learnt from past failures in Alzheimer’s disease drug discovery?
Ramón Cacabelos
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 4, pp. 309-323
Open Access | Times Cited: 18
Ramón Cacabelos
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 4, pp. 309-323
Open Access | Times Cited: 18
Stability and anti-proliferative properties of biologically active compounds extracted from Cistus L. after sterilization treatments
Mario Ammendola, Monika Hapońska, Karolina Balik, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Mario Ammendola, Monika Hapońska, Karolina Balik, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Personalized Management and Treatment of Alzheimer’s Disease
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Life (2022) Vol. 12, Iss. 3, pp. 460-460
Open Access | Times Cited: 13
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Life (2022) Vol. 12, Iss. 3, pp. 460-460
Open Access | Times Cited: 13
Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Methods in molecular biology (2022), pp. 275-387
Closed Access | Times Cited: 13
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, et al.
Methods in molecular biology (2022), pp. 275-387
Closed Access | Times Cited: 13
Pharmacogenomics of drugs used to treat brain disorders
Ramón Cacabelos
Expert Review of Precision Medicine and Drug Development (2020) Vol. 5, Iss. 3, pp. 181-234
Closed Access | Times Cited: 20
Ramón Cacabelos
Expert Review of Precision Medicine and Drug Development (2020) Vol. 5, Iss. 3, pp. 181-234
Closed Access | Times Cited: 20
Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics
Ramón Cacabelos, Iván Carrera, Olaia Martínez, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 5, pp. 2841-2886
Closed Access | Times Cited: 12
Ramón Cacabelos, Iván Carrera, Olaia Martínez, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 5, pp. 2841-2886
Closed Access | Times Cited: 12
Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
Ramón Cacabelos, Juan C. Carril, Lola Corzo, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 366-366
Open Access | Times Cited: 8
Ramón Cacabelos, Juan C. Carril, Lola Corzo, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 366-366
Open Access | Times Cited: 8
Epigenetics in personalized toxicity
Laura Corveleyn, Sigrid Verhelst, Dieter Deforce, et al.
Elsevier eBooks (2024), pp. 229-248
Closed Access
Laura Corveleyn, Sigrid Verhelst, Dieter Deforce, et al.
Elsevier eBooks (2024), pp. 229-248
Closed Access
Adli Toksikolojide Analiz Yöntemleri
Tuğba Tekin Bülbül, Zeynep Türkmen
(2023)
Open Access | Times Cited: 1
Tuğba Tekin Bülbül, Zeynep Türkmen
(2023)
Open Access | Times Cited: 1
Adli Toksikoloji: Temel Kavramlar ve Prensipler
Işıl Bavunoğlu, Merve Kuloglu, Murat Yayla, et al.
(2023)
Open Access
Işıl Bavunoğlu, Merve Kuloglu, Murat Yayla, et al.
(2023)
Open Access
Toksik Maddelerin Sınıflandırılması
Merve Kuloglu, Tuğba Tekin Bülbül, Sümeyye Zülal Şimşek, et al.
(2023)
Open Access
Merve Kuloglu, Tuğba Tekin Bülbül, Sümeyye Zülal Şimşek, et al.
(2023)
Open Access
Adli Toksikoloji Laboratuvarı ve Yöntem Geçerliliği
Tuğba Tekin Bülbül, Murat Yayla, Selda Mercan
(2023)
Open Access
Tuğba Tekin Bülbül, Murat Yayla, Selda Mercan
(2023)
Open Access
Adli Toksikolojide Kullanılan Deliller ve Numune Hazırlama Yöntemleri
Simge Zengin, Merve Kuloğlu Genç, Zeynep TÜRKMEN, et al.
(2023)
Open Access
Simge Zengin, Merve Kuloğlu Genç, Zeynep TÜRKMEN, et al.
(2023)
Open Access
